Neurocrine Biosciences Inc (NBIX) net margin is 12.7%
Neurocrine Biosciences Inc (NBIX) net margin is 12.7% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full NBIX research page for quote, filings, and the rest of the model. This satellite exists so “Neurocrine Biosciences Inc net margin” can rank with the actual number, then send you to /stock/nbix.